SEC Filing Summary: Flotek Industries Inc. (8-K)
Business Context and Reporting Period
Company: Flotek Industries Inc.
Filing Date: October 12, 2001
Event Date: August 15, 2001
Subject: Agreement and Plan of Reorganization with Chemical & Equipment Specialties, Inc. (CESI).
Transaction Type: Merger of CESI into a Flotek subsidiary. For accounting purposes, the transaction is treated as an acquisition of Flotek by CESI (reverse merger) because CESI shareholders will own a majority of the combined entity. The combined company will adopt CESI's fiscal year ending December 31.
Key Financial Metrics and Capital Structure
- Cash Proceeds: As of October 4, 2001, the Company received $1,865,236 in cash from the exercise of warrants to purchase 62,174,555 shares.
- Warrant Exercise Price Adjustment: New warrants ("New Warrants") will have an exercise price of $0.12 per share, increased from the previous $0.03.
- Preferred Stock Conversion: At least 1,903 shares of Preferred Stock are required to be converted into Common Stock at a price of $0.027 per share (reduced from the original $0.03).
- Target Financials (CESI): CESI reported consolidated pro-forma revenues of approximately $10 million for the year ended December 31, 2000.
- Debt and Liquidity: The filing does not provide specific values for total debt, current liquidity ratios, or net income for Flotek Industries Inc. at the time of filing.
Material Changes and Transaction Terms
- Ownership Structure: Upon closing, CESI shareholders will own a minimum of 61.5% (potentially up to 61.8%) of the fully-diluted shares of the combined company. Existing Flotek shareholders will own between 38.2% and 38.5%.
- Warrant Conditions: The merger is contingent on at least 63,419,738 outstanding warrants being either exercised or replaced with New Warrants. Additionally, at least 59,896,419 warrants must be exercised for cash. As of October 4, 2001, these conditions were satisfied.
- Preferred Stock Conditions: All outstanding Preferred Stock must be converted into Common Stock at the $0.027 price effective with the Merger closing. This condition was satisfied as of October 4, 2001.
- Accounting Treatment: The combined company will report the historical results of CESI. Flotek's results will only be incorporated for periods subsequent to the closing.
Outlook, Risks, and Management Commentary
- Closing Expectation: Management expects the Merger to close on or about October 31, 2001, subject to satisfaction of material conditions.
- Business Scope: The combined entity will operate in the oil field service industry, focusing on chemical development/blending, equipment manufacturing (nitrogen/fracturing pumpers, cement mixing units), and engineering/design for bulk material handling.
- Risks: Forward-looking statements are subject to risks including market acceptance of products, competitive pricing, ability to obtain financing, and success of R&D.
- Unusual Items: The transaction involves a significant restructuring of the capital base, including the acceleration of warrant expiration dates if the stock price exceeds 150% of the exercise price for a specified period.
Investor Verification Checklist
- Verify the final closing date of the Merger (expected October 31, 2001) and confirm all conditions precedent have been met.
- Confirm the exact number of shares issued to CESI shareholders and the resulting fully-diluted ownership percentages.
- Review the audited financial statements of CESI to validate the $10 million revenue figure and assess the pro-forma financial health of the combined entity.
- Monitor the status of the "New Warrants" and ensure the $0.12 exercise price and revised expiration terms are correctly implemented.
- Check for any subsequent filings regarding the reincorporation of Flotek from Alberta, Canada, to Delaware, which is permitted under the agreement.